Associated Papers
Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III.
Thakur S et al.
Biochemistry and Biophysics Reports, 2025
Corrigendum to "APOE gene variants in primary dyslipidemia" [Atherosclerosis (2021 Jul) 328 11-22].
Abou Khalil Y et al.
Atherosclerosis, 2023
Genetics of Alzheimer's disease: an East Asian perspective.
Miyashita A et al.
Journal of Human Genetics, 2023
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
Heidemann BE et al.
Clinical Genetics, 2022
35781703 (PubMed )
Supplement: CGE-102-253-s001.docx
Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology.
Morani F et al.
Frontiers in Neurology, 2020
33584503 (PubMed )
Supplement: Table_3.XLSX › A
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.
Zhou Y et al.
Journal of Lipid Research, 2018
30076208 (PubMed )
Supplement: 10.1194_P086710_jlr.P086710-4.xlsx › APOE
In silico analyses of deleterious missense SNPs of human apolipoprotein E3.
Pires AS et al.
Scientific Reports, 2017
28559539 (PubMed )
Supplement: 41598_2017_1737_MOESM1_ESM.docx
Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.
Dasari S et al.
Journal of Proteome Research, 2014
24650283 (PubMed )
Supplement: pr4011475_si_001.pdf
Genome-wide family-based linkage analysis of exome chip variants and cardiometabolic risk.
Hellwege JN et al.
Genetic Epidemiology, 2014
Screening and Evaluation of Deleterious SNPs in APOE Gene of Alzheimer's Disease.
Masoodi TA et al.
Neurology Research International, 2012
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.
Koopal C et al.
Journal of Clinical Lipidology, 0
Select a paper to view details